<DOC>
	<DOCNO>NCT03013634</DOCNO>
	<brief_summary>The purpose study evaluate protective effect dexmedetomidine myocardial injury liver transplantation</brief_summary>
	<brief_title>Protective Effects Dexmedetomidine Myocardial Injury During Liver Transplantation</brief_title>
	<detailed_description>Liver transplantation surgery may lead myocardial injury . Dexmedetomidine , highly specific Î±2-adrenoeptor agonist , sedative analgesic property without significant respiratory depression clinically approve dosage . Some investigation indicate dexmedetomidine able protect myocardium via improve activity Na+-K+-adenosine triphosphate enzyme Ca2+-adenosine triphosphate , alleviate inflammation reaction avoid Ca2+ overload . However , effect mechanism dexmedetomidine myocardial injury liver transplantation remain unclear .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>End stage liver disease schedule liver transplantation Tianjin First Center Hospital Preexisting respiratory failure , renal failure , hepatic encephalopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>dexmedetomidine</keyword>
</DOC>